Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER is a chemical compound that belongs to the group of quinoline carboxylic acid esters. It is an ethyl ester derivative of quinoline, which contains a hydroxy group at the 4-position and a trifluoromethyl group at the 8-position. 4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER is commonly used in organic synthesis and medicinal chemistry as a building block or intermediate for the preparation of various pharmaceuticals and agrochemicals. It has also been studied for its potential biological activities, including anti-inflammatory and anticancer properties.

23851-84-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 23851-84-5 Structure
  • Basic information

    1. Product Name: 4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER
    2. Synonyms: 4-hydroxy-8-(trifluoromethyl)-3-quinolinecarboxylicacidethylester;4-hydroxy-8-(trifluoromethyl)-3-quinolinecarboxylicaciethylester;BUTTPARK 10\01-31;ETHYL 4-HYDROXY-8-(TRIFLUOROMETHYL)-3-QUINOLINECARBOXYLATE;ETHYL 4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLATE;4-HYDROXY-8-TRIFLUOROMETHYLQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER;4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER;AKOS BBS-00002777
    3. CAS NO:23851-84-5
    4. Molecular Formula: C13H10F3NO3
    5. Molecular Weight: 285.22
    6. EINECS: 245-914-2
    7. Product Categories: blocks;Carboxes;Quinolines;Acids and Derivatives;Heterocycles;Quinoline&Isoquinoline
    8. Mol File: 23851-84-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 352.2 °C at 760 mmHg
    3. Flash Point: 166.8 °C
    4. Appearance: /
    5. Density: 1.373 g/cm3
    6. Vapor Pressure: 0.00647mmHg at 25°C
    7. Refractive Index: 1.473
    8. Storage Temp.: Inert atmosphere,Room Temperature
    9. Solubility: N/A
    10. CAS DataBase Reference: 4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER(23851-84-5)
    12. EPA Substance Registry System: 4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER(23851-84-5)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 23851-84-5(Hazardous Substances Data)

23851-84-5 Usage

Uses

Used in Pharmaceutical Industry:
4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER is used as a building block or intermediate for the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be incorporated into the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER is used as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its chemical properties make it suitable for the development of effective and targeted agrochemicals.
Used in Organic Synthesis:
4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER is used as a versatile intermediate in organic synthesis. Its functional groups, such as the hydroxy and trifluoromethyl groups, enable various chemical reactions, allowing for the formation of a wide range of organic compounds.
Used in Medicinal Chemistry Research:
4-HYDROXY-8-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ETHYL ESTER is used in medicinal chemistry research for the exploration of its potential biological activities. Studies have shown that it possesses anti-inflammatory and anticancer properties, making it a promising candidate for further research and development in the field of drug discovery.

Check Digit Verification of cas no

The CAS Registry Mumber 23851-84-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,8,5 and 1 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 23851-84:
(7*2)+(6*3)+(5*8)+(4*5)+(3*1)+(2*8)+(1*4)=115
115 % 10 = 5
So 23851-84-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H12F3N3/c1-8(2,3)5-4-6(9(10,11)12)15-7(13)14-5/h4H,1-3H3,(H2,13,14,15)

23851-84-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 4-oxo-8-(trifluoromethyl)-1H-quinoline-3-carboxylate

1.2 Other means of identification

Product number -
Other names Ethyl 4-Hydroxy-8-(trifluoromethyl)-3-quinolinecarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23851-84-5 SDS

23851-84-5Downstream Products

23851-84-5Relevant articles and documents

Click chemistry approach: Regioselective one-pot synthesis of some new 8-trifluoromethylquinoline based 1,2,3-triazoles as potent antimicrobial agents

Garudachari,Isloor, Arun M.,Satyanarayana,Fun, Hoong-Kun,Hegde, Gurumurthy

, p. 324 - 332 (2014/02/14)

Three series of 8-trifluoromethylquinoline based 1,2,3-triazoles derivatives (5a-c, 6a-d and 7a-c) were synthesized by multi-step reactions by click chemistry approach. Synthesized compounds were characterized by spectral studies and X-ray analysis. The final compounds were screened for their in-vitro antimicrobial activity by well plate method (zone of inhibition). Compounds 5c, 6b, 8b, 11 and 12 were found to be active against tested microbial strains. The results are summarized in Tables 5 and 6.

How to convert a walk-in hood into a manufacturing facility: Demonstration of a continuous, high-temperature cyclization to process solids in flow

White, Timothy D.,Alt, Charles A.,Cole, Kevin P.,Groh, Jennifer McClary,Johnson, Martin D.,Miller, Richard D.

, p. 1482 - 1491 (2015/02/19)

An intramolecular thermal cyclization protocol was developed in a flow reactor to take advantage of the high pressures and temperatures that are easily obtained in small scale autoclave reactors that have been modified to handle slurries. This reactor was equipped with a fill/empty pumping system to enable easy and nearly complete transfer of slurries. The reaction conditions were designed to take advantage of the insolubility of the product in order to separate it from residual starting material by filtration after short reaction times. Recycling of the filtrate maximized the yield and throughput while minimizing decomposition. Recycles were accomplished using a strip to dryness protocol that was easily performed in a rotary evaporator. This new equipment set was designed with lab-hood manufacturing in mind, a minimized footprint, and the system was completely automated for charging, emptying, rinsing, and reacting. Additional efforts for quick screening and alternate modes of addition were also investigated.

Design and regioselective synthesis of trifluoromethylquinolone derivatives as potent antimicrobial agents

Garudachari,Isloor, Arun M.,Satyanarayana,Fun, Hoong-Kun,Pavithra,Kulal, Ananda

, p. 422 - 432 (2013/10/01)

Three series of new trifluoromethyl substituted quinolone derivatives were synthesized (4a-f, 6a-f and 8a-f) from corresponding substituted anilines by multi-step reactions. The regioselective alkylation with different alkyl halides were carried out by approaching two different routes to get the final products in good yield. Newly synthesized compounds were characterized by spectral study and also by C, H, N analyses. Three dimensional structure of 2b and 4b were also confirmed by single crystal X-ray studies. The final compounds (4a-f, 6a-f and 8a-f) were screened for their in-vitro antibacterial and antifungal activity by well plate method (zone of inhibition). The results revealed that, compounds 4a, 6b, 6c and 8e showed significant antibacterial activity as compared to the standard drug Ciprofloxacin. The compound 8a was found to be a potent antifungal agent.

Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents

Thomas,Adhikari, Airody Vasudeva,Telkar, Sandeep,Chowdhury, Imran H.,Mahmood, Riaz,Pal, Nishith K.,Row, Guru,Sumesh

, p. 5283 - 5292 (2011/12/14)

Three new series of 4-hydroxy-8-trifluoromethyl-quinoline derivatives were synthesized through multi step reactions. All the newly synthesized compounds were characterized by spectral and elemental analyses. The structure of 5j was evidenced by X-ray crystallographic study. The newly synthesized title compounds were evaluated for their antimicrobial activities including antimycobacterial activity. Amongst the tested compounds, 5b, 5e, 5h, 5j, 6c and 7c displayed promising antimicrobial activity. The mode of action of these active compounds was carried out by docking of receptor enoyl-ACP reductase with newly synthesized candidate ligands, 5b, 5e, 5h, 5j and 6c.

Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents

Eswaran, Sumesh,Adhikari, Airody Vasudeva,Pal, Nishith K.,Chowdhury, Imran H.

supporting information; experimental part, p. 1040 - 1044 (2010/06/14)

A series of 26 new quinoline derivatives carrying active pharmacophores has been synthesized and evaluated for their in vitro antituberculosis activity against Mycobacterium tuberculosis H37Rv (MTB), Mycobacterium smegmatis (MC2), and Mycobacterium fortuitum following the broth micro dilution assay method. Compounds 13e, 13i, 13k, 14a, 14c, 14i, and 14k exhibited significant minimum inhibition concentrations, when compared with first line drugs isoniazid (INH) and rifampicin (RIF) and could be ideally suited for further modifications to obtain more efficacious compounds in the fight against multi-drug resistant tuberculosis.

Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRβ and low blood-brain penetration

Hu, Baihua,Bernotas, Ron,Unwalla, Rayomand,Collini, Michael,Quinet, Elaine,Feingold, Irene,Goos-Nilsson, Annika,Wilhelmsson, Anna,Nambi, Ponnal,Evans, Mark,Wrobel, Jay

scheme or table, p. 689 - 693 (2010/06/14)

A series of quinoline-3-carboxamide containing sulfones was prepared and found to have good binding affinity for LXRβ and moderate binding selectivity over LXRα. The 8-Cl quinoline analog 33 with a high TPSA score, displayed 34-fold binding selectivity for LXRβ over LXRα (LXRβ IC50 = 16 nM), good activity for inducing ABCA1 gene expression in a THP macrophage cell line, desired weak potency in the LXRα Gal4 functional assay, and low blood-brain barrier penetration in rat.

Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety

Eswaran, Sumesh,Adhikari, Airody Vasudeva,Shetty, N. Suchetha

experimental part, p. 4637 - 4647 (2009/12/26)

A new class of quinoline derivatives containing 1,2,4-triazole moiety were synthesized from derivatives of 4-hydroxy-8-(trifluoromethyl)quinoline-3-carbohydrazide 4 through multi-step reactions. The compound 4, on treatment with substituted Isothiocyanates yielded quinoline-thiosemicarbazides 5a-c, which were conveniently cyclized to (5-mercapto-4H-triazol-3-yl)-quinolin-4-ols 6a-c in basic medium. These intermediates were then transformed to their respective chloro derivatives 7a-c by treatment with phosphorus oxychloride, which on further reaction with different biologically active rare amines yielded the target compounds 8a-g, 9a-h and 10a-h in good yield. The ultimate step, involving nucleophilic substitution reaction was achieved by microwave-induced technique, which has reduced the reaction time drastically as well as improved the yield when compared to conventional heating. The newly synthesized final compounds were evaluated for their in vitro antibacterial and antifungal activities against four strains each. Preliminary results indicated that most of the compounds demonstrated very good antimicrobial activity, comparable to the first line standard drugs. The most effective compounds have exhibited activity at MIC of 6.25 μg/mL.

Quinolines useful in treating cardiovascular disease

-

Page/Page column 28, (2008/06/13)

This invention provides compounds of formula I that are useful in the treatment or inhibition of LXR mediated diseases.

Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors

Zask,Gu,Albright,Du,Hogan,Levin,Chen,Killar,Sung,DiJoseph,Sharr,Roth,Skala,Jin,Cowling,Mohler,Barone,Black,March,Skotnicki

, p. 1487 - 1490 (2007/10/03)

Potent and selective bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors were synthesized by a novel convergent route. Selectivity and efficacy versus MMPs and TACE could be controlled by appropriate substitution on the scaffolds and by variation of the P1′ group. Select compounds were found to be effective in in vivo models of arthritis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23851-84-5